RAYMOND JAMES & ASSOCIATES - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 93 filers reported holding CYTOSORBENTS CORP in Q4 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q1 2022$276,000
-23.8%
86,5000.0%0.00%
Q4 2021$362,000
-48.4%
86,5000.0%0.00%
-100.0%
Q3 2021$702,000
+7.5%
86,5000.0%0.00%0.0%
Q2 2021$653,000
-65.5%
86,500
-60.3%
0.00%
-50.0%
Q1 2021$1,893,000
+9.0%
218,050
+0.1%
0.00%0.0%
Q4 2020$1,736,000
-0.3%
217,800
-0.2%
0.00%0.0%
Q3 2020$1,741,000
-20.0%
218,300
-0.7%
0.00%
-33.3%
Q2 2020$2,176,000
+28.1%
219,8000.0%0.00%0.0%
Q1 2020$1,699,000
+207.8%
219,800
+53.4%
0.00%
+200.0%
Q4 2019$552,000
-50.1%
143,300
-34.8%
0.00%
-50.0%
Q3 2019$1,106,000
-0.9%
219,800
+30.2%
0.00%0.0%
Q2 2019$1,116,000
-12.7%
168,8000.0%0.00%0.0%
Q1 2019$1,278,000
-6.3%
168,8000.0%0.00%0.0%
Q4 2018$1,364,000
-29.2%
168,800
+13.1%
0.00%
-33.3%
Q3 2018$1,926,000
+0.8%
149,300
-10.9%
0.00%0.0%
Q2 2018$1,911,000
+62.2%
167,600
+0.3%
0.00%
+50.0%
Q1 2018$1,178,000
+81.2%
167,100
+67.1%
0.00%
+100.0%
Q4 2017$650,000
+109.7%
100,000
+100.0%
0.00%0.0%
Q3 2017$310,000
+44.2%
50,0000.0%0.00%
Q2 2017$215,000
+88.6%
50,000
+96.5%
0.00%
Q1 2017$114,000
-68.1%
25,442
-61.1%
0.00%
-100.0%
Q4 2016$357,000
-38.3%
65,442
-27.6%
0.00%
-50.0%
Q3 2016$579,000
-60.8%
90,442
-72.1%
0.00%
-60.0%
Q2 2016$1,477,000
+385.9%
324,603
+318.6%
0.01%
+400.0%
Q1 2016$304,000
-62.4%
77,551
-39.5%
0.00%
-66.7%
Q3 2015$809,000128,2020.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 249,430$2,015,0001.24%
Manatuck Hill Partners, LLC 194,100$1,568,0000.81%
Skylands Capital, LLC 495,850$4,006,0000.66%
EAM Global Investors LLC 78,027$630,0000.34%
EAM Investors, LLC 107,531$869,0000.24%
Granahan Investment Management 278,170$2,248,0000.16%
Wealthcare Advisory Partners LLC 62,079$502,0000.10%
Avenir Corp 76,390$617,0000.08%
Crow Point Partners, LLC 48,576$380,0000.07%
Kalos Management, Inc. 14,700$120,0000.06%
View complete list of CYTOSORBENTS CORP shareholders